Toll Free 1 800 586 2325
| Antidepressant | ||||
| Cipralex® | Product Monograph | Patient Information | ||
| Celexa® | Patient Information | |||
| TrintellixTM | Product Monograph | Patient Information | ||
| Antipsychotics | ||||
| Clopixol® | Product Monograph | Patient Information | HCP Communication 2011 | |
| Clopixol Acuphase® | Product Monograph | Patient Information | HCP Communication 2011 | |
| Clopixol Depot® | Product Monograph | Patient Information | HCP Communication 2011 | |
| Fluanxol® | Product Monograph | Patient Information | ||
| Fluanxol Depot® | Product Monograph | Patient Information | HCP Communication 2011 | |
| Saphris® | Product Monograph | Patient Information | ||
| Abilify Maintena™ | Product Monograph | Patient Information | ||
| REXULTI™ | Product Monograph | Patient Information | ||
| Alzheimer's | ||||
|
Ebixa®
|
|
|
||
| Anti-epileptics | ||||
| Frisium® | Product Monograph | Patient Information | ||
| Sabril® | Product Monograph | Patient Information |
*Ebixa® is a registered trademark of Merz Pharma GmbH, under license to Lundbeck Canada Inc.
SAPHRIS® is a registered trademark of Merck Sharp & Dohme B.V., used by Lundbeck Canada Inc. under license.
The product monographs provided here are identical to those posted on Health Canada's website with the exception of the removal of those strengths and/or presentations which are not currently available on the Canadian market as well as Lundbeck Canada's updated address information.
Abilify Maintena™ is a Trademark of Otsuka Pharmaceutical Co., Ltd, marketed by Otsuka Canada Pharmaceutical Inc., and Lundbeck Canada Inc.
Frisium® and Sabril® are Lundbeck LLC products. For medical information regarding these products, please visit the Lundbeck US Product site.
